Blog

Prof Shabir Madhi awarded CBE

2023-11-07T11:46:22+02:0002 Nov 2023|

Team VIDA out-and-about in the community

Team VIDA out-and-about in the community

2023-11-08T12:16:14+02:0031 Oct 2023|

Meet Vaccinologist, Prof Shabir Madhi – Lifetime Award winner

2023-06-30T12:08:01+02:0030 Jun 2023|

Wits VIDA publishes important work on interrogating Covid vaccine hesitancy in Soweto

Wits VIDA publishes important work on interrogating Covid vaccine hesitancy in Soweto

2022-12-29T12:57:17+02:0002 Dec 2022|

Witsies win lifetime achievement, research, and capacity development awards at Science Oscars

Witsies win lifetime achievement, research, and capacity development awards at Science Oscars

2022-08-06T10:57:37+02:0022 Jul 2022|

Novavax Covid-19 vaccine trial results show efficacy against the B.1.351 variant in SA study

Novavax Covid-19 vaccine trial results show efficacy against the B.1.351 variant in SA study

2022-03-25T09:56:47+02:0025 Mar 2022|

New masks regulations met with mixed reactions

2022-03-25T09:00:27+02:0023 Mar 2022|

New project will examine Covid-19 vaccine acceptance in southern Africa

New project will examine Covid-19 vaccine acceptance in southern Africa

2022-03-25T09:40:49+02:0016 Mar 2022|

The goal: Vaccinate 70% of the world against COVID. Scientists are proposing a reboot

2022-03-25T08:49:59+02:0014 Mar 2022|

New promising interventions to protect term and premature babies from deadly respiratory virus

New promising interventions to protect term and premature babies from deadly respiratory virus

2022-03-25T09:41:50+02:0011 Mar 2022|

COVID-19 | Discussion | Why are the side-effects trending?

2022-03-25T08:53:19+02:0010 Mar 2022|

Population based survey reveals why SA is at a turning point in the pandemic

2022-03-25T09:37:30+02:0024 Feb 2022|